This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mann JR and DuBois RN (2004). Cyclooxygenase-2 and gastrointestinal cancer. Cancer J 10: 145–152
Singh G and Triadafilopoulos G (1999) Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 56 (Suppl): S18–S24
Chan FK and Graham DY (2004) Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications—review and recommendations based on risk assessment. Aliment Pharmacol Ther 19: 1051–1061
Topol EJ and Falk GW (2004) A coxib a day won't keep the doctor away. Lancet 364: 639–640
Garcia Rodriguez LA and Jick H (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343: 769–772
El Serag HB et al. (2002) Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost- effectiveness analysis. Arch Intern Med 162: 2105–2110
Graham DY (2002) Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter 7: 1–8
Chan FK et al. (2002) Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347: 2104–2110
Morris AL et al. (1994) Short report: the effect of misoprostol on the anaemia of NSAID enteropathy. Aliment Pharmacol Ther 8: 343–346
Laine L et al. (2003) Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 124: 288–292
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Graham, D., Chan, F. Is the use of COX-2 inhibitors in gastroenterology cost-effective?. Nat Rev Gastroenterol Hepatol 1, 60–61 (2004). https://doi.org/10.1038/ncpgasthep0043
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0043